Zhejiang Ausun Pharmaceutical Co Ltd (603229) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.052x

Based on the latest financial reports, Zhejiang Ausun Pharmaceutical Co Ltd (603229) has a cash flow conversion efficiency ratio of 0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥121.49 Million ≈ $17.78 Million USD) by net assets (CN¥2.35 Billion ≈ $343.48 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Zhejiang Ausun Pharmaceutical Co Ltd (603229) defensive interval to measure how many days the company can operate on defensive assets alone.

Zhejiang Ausun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Zhejiang Ausun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Zhejiang Ausun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Zhejiang Ausun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Henan Ancai Hi-tech Co Ltd SHG:600207	-0.033x
Jiangsu Maixinlin Aviation Science & Technology Corp. A SHG:688685	0.244x
AMAG Austria Metall AG VI:AMAG	0.035x
SK ETERNIX CO LT KO:475150	0.497x
BIRLASOFT LIMITED NSE:BSOFT	0.031x
Healthcare Global Enterprises Limited NSE:HCG	0.136x
Sinodata Co Ltd SHE:002657	0.002x
Everlight Electronics Co Ltd TW:2393	0.011x

Annual Cash Flow Conversion Efficiency for Zhejiang Ausun Pharmaceutical Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Zhejiang Ausun Pharmaceutical Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Zhejiang Ausun Pharmaceutical Co Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥2.27 Billion ≈ $332.08 Million	CN¥156.51 Million ≈ $22.90 Million	0.069x	-11.94%
2024-12-31	CN¥2.27 Billion ≈ $332.45 Million	CN¥177.93 Million ≈ $26.04 Million	0.078x	-24.40%
2023-12-31	CN¥2.14 Billion ≈ $313.38 Million	CN¥221.85 Million ≈ $32.46 Million	0.104x	+25.54%
2022-12-31	CN¥1.46 Billion ≈ $213.81 Million	CN¥120.57 Million ≈ $17.64 Million	0.083x	-40.46%
2021-12-31	CN¥1.25 Billion ≈ $183.62 Million	CN¥173.90 Million ≈ $25.45 Million	0.139x	+12.78%
2020-12-31	CN¥1.13 Billion ≈ $164.90 Million	CN¥138.47 Million ≈ $20.26 Million	0.123x	-9.63%
2019-12-31	CN¥645.19 Million ≈ $94.41 Million	CN¥87.73 Million ≈ $12.84 Million	0.136x	+606.38%
2018-12-31	CN¥597.60 Million ≈ $87.45 Million	CN¥11.50 Million ≈ $1.68 Million	0.019x	-76.76%
2017-12-31	CN¥564.93 Million ≈ $82.67 Million	CN¥46.78 Million ≈ $6.85 Million	0.083x	-78.38%
2016-12-31	CN¥243.30 Million ≈ $35.60 Million	CN¥93.21 Million ≈ $13.64 Million	0.383x	+34.36%
2015-12-31	CN¥188.07 Million ≈ $27.52 Million	CN¥53.63 Million ≈ $7.85 Million	0.285x	+3.96%
2014-12-31	CN¥78.21 Million ≈ $11.44 Million	CN¥21.45 Million ≈ $3.14 Million	0.274x	-42.62%
2013-12-31	CN¥32.91 Million ≈ $4.82 Million	CN¥15.73 Million ≈ $2.30 Million	0.478x	+534.85%
2012-12-31	CN¥10.36 Million ≈ $1.52 Million	CN¥-1.14 Million ≈ $-166.57K	-0.110x	--

About Zhejiang Ausun Pharmaceutical Co Ltd

SHG:603229 China Biotechnology

Market Cap

$986.57 Million

CN¥6.74 Billion CNY

Market Cap Rank

#9117 Global

#2311 in China

Share Price

CN¥8.12

Change (1 day)

-2.17%

52-Week Range

CN¥8.12 - CN¥12.31

All Time High

CN¥1598.02